Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / Mapping Cancer Through Cell Surface Sugars
Oncology Biochemistry and molecular biology Microscopy and imaging Research and Innovations

Mapping Cancer Through Cell Surface Sugars

New imaging approach identifies distinct glycan signatures in tumors, immune cells, and healthy tissue

06/01/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions

Share

Top Institutions in Oncology

Ranking combines internal corpus citation frequency with web search results due to limited internal data for this topic.

  • #1

    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Dana-Farber is recognized for its comprehensive cancer care and research, particularly in glycoscience through its National Center for Functional Glycomics.

    Key Differentiators

    • Oncology
  • #2

    Stanford University – Stanford Cancer Institute

    Stanford, California

    Stanford's Bertozzi Lab focuses on the cancer glycocalyx and glycan-targeted therapeutics, supported by NIH funding.

    Key Differentiators

    • Oncology
  • #3

    Massachusetts General Hospital

    Boston, Massachusetts

    Massachusetts General Hospital is involved in significant cancer research and has contributed to studies linking treatment responses to cell surface sugars.

    Key Differentiators

    • Oncology
  • #4

    Memorial Sloan Kettering Cancer Center

    New York, New York

    Memorial Sloan Kettering is a leader in cancer research and treatment, with contributions to understanding the role of glycans in cancer.

    Key Differentiators

    • Oncology
  • #5

    Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee

    Vanderbilt-Ingram Cancer Center manages personalized cancer medicine resources and is involved in innovative cancer research.

    Key Differentiators

    • Oncology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Intense Intestines
Microscopy and imaging
Intense Intestines

January 19, 2024

1 min read

Some powerful fluorescent microscopy in this Image of the Month…

Context Matters in Cancer Biology
Microscopy and imaging
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

When Pathology Goes 3D
Microscopy and imaging
When Pathology Goes 3D

February 2, 2022

1 min read

Stratifying cancers with non-destructive 3D pathology

Sacrificing Safety for Speed?
Microscopy and imaging
Sacrificing Safety for Speed?

February 4, 2022

3 min read

Wide adaptation of antigen testing could increase the risk of exposure to infectious SARS-CoV-2 samples

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.